7Holland R W, Nimmo C M. Transitions, partl : beyond pharmaceutical care[J]. Am J Health-Syst Pharm, 1999, 56:1758 - 1764.
8Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women' s Health Initiative randomized controlled trial[J]. JAMA, 2002, 288(3):321 -333.
9Lacey J V Jr, Mink P J, Lubin J H, et al. Menopausal hormone replacement therapy and risk of ovarian cancer[J]. JAMA, 2002, 288(3) :334 - 341.
10Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: heart and estrogen/progestin replacement study follow-up (HERS Ⅱ)[J]. J AMA, 2002, 288(1):58-66.
